MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study - Wikidata - wikimedia - TriplyDB

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study

http://www.wikidata.org/entity/Q30983821

about

Exercise training in idiopathic pulmonary fibrosis: is it of benefit?Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials Dyspnea in Chronic Fatigue Syndrome (CFS): comparison of two prospective cross-sectional studies Outcome of endoscopic resection tracheoplasty for treating lambdoid tracheal stomal stenosis.Medical Research Council dyspnea scale does not relate to fibroblast foci profusion in IPF.Pulmonary rehabilitation: An overview.Recumbent stepper submaximal exercise test to predict peak oxygen uptake.A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.Emergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified?Outcome Measures for Clinical Trials in Interstitial Lung Diseases.Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis Oxygen desaturation during a 6-minute walk test as a predictor of maximal exercise-induced gas exchange abnormalities in sarcoidosis.The Role of Cardiopulmonary Exercise Test in IPF Prognosis.Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting.Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies.Daily physical activity affects exercise capacity in patients with idiopathic pulmonary fibrosis.The COPD Assessment Test as a Prognostic Marker in Interstitial Lung Disease.Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia.Population pharmacokinetics of inhaled umeclidinium and vilanterol in patients with chronic obstructive pulmonary disease.Psycho-Physiological Associates of Dyspnea in Hospitalized Patients with Interstitial Lung Diseases: A Cross-Sectional Study.Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.

P2860

Q26740857-0C811638-0838-428C-9F7D-E55DEE630DFE Q27024062-7E8AC3FF-AFD8-4B8A-8362-EC88751999C9 Q34403726-FFC5DD32-F414-493A-9E54-2F62A8A4C3AE Q34638835-051101F0-A0BF-406D-AC31-3FC9B80AD722 Q34870967-EB594DA0-DB9D-4108-821D-A0DB5393F948 Q35542883-9BB97C15-A63C-4410-B304-12B05FA7DA97 Q36071844-4755DD68-6D21-4967-BD6A-96A032C8C130 Q36235136-AE612D5F-6D8A-4237-8B82-8BA6E1EBD629 Q36652471-252C1EDD-8152-40B9-94E2-7303825F22FA Q36726418-B88EEA53-DB32-41FE-A4BE-6FF807D7F929 Q36860416-11904FB2-9619-47D4-977A-35590EE4DFE5 Q37208719-2ADD139A-700C-4F9A-A0BB-6E2AD875DDDF Q37323225-5FD07D1D-B080-499A-A934-A7D210317A02 Q38663444-E478C6FE-6027-4210-A268-4FDE3607C938 Q40449015-50D3C334-3091-44D7-9BA1-4D09814A021C Q41543589-C05F80B4-B075-497B-BF9F-4EBAE651685E Q41642420-E7F674A4-F587-4317-9B86-9F39DA062E41 Q41833843-BE60ED93-FD3B-4B60-B173-DA3D0B704C50 Q43936195-3ADDFDA5-87D0-453E-A25F-517E39D712F5 Q47104446-91CDEEF0-4ED7-4BCD-A594-A3D38E29921A Q47694163-72948228-CC7D-4EA8-9775-CE5EF64A326A Q51060153-99A7B81E-321A-4342-8EC9-D2E5BA2DF674

P2860

MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study

http://www.wikidata.org/entity/Q30983821

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

MRC chronic Dyspnea Scale: Rel ...... patients: a prospective study

@ast

MRC chronic Dyspnea Scale: Rel ...... patients: a prospective study

@en

type

label

MRC chronic Dyspnea Scale: Rel ...... patients: a prospective study

@ast

MRC chronic Dyspnea Scale: Rel ...... patients: a prospective study

@en

prefLabel

MRC chronic Dyspnea Scale: Rel ...... patients: a prospective study

@ast

MRC chronic Dyspnea Scale: Rel ...... patients: a prospective study

@en

P1433

Q30983821-C0EA3B83-6F46-4094-88EA-5418FA7097BC

P1476

Q30983821-19DD98B4-A037-4072-98B2-CB4DBE78134A

P2093

Q30983821-36A22B1E-8B5D-436B-A788-98C671691442

Q30983821-5CF77561-A30B-4DC1-BED6-E089D40CC534

Q30983821-6B13EEDC-4E1A-4873-9101-63C29912FF0D

Q30983821-8A246F9B-ABBA-4352-9619-0919513D3189

Q30983821-91826969-961B-429A-8215-5487E335AACB

Q30983821-C50D1EC3-D86B-415A-9841-E7F5D87B286E

Q30983821-C9EEA81E-2345-448F-8990-16F45401420E

Q30983821-E71DAE53-9B12-4478-AFCF-EC8C5D4D248F

P2860

Q30983821-05665F60-09A3-4A0C-B859-2F311C4E004A

Q30983821-056EA943-DE4A-4131-BB70-63E4F0229636

Q30983821-08CD73F2-43AE-40B0-899A-E9D0262C9D2C

Q30983821-09FAA21B-D759-4CD6-B8E0-243C2EB90133

Q30983821-0D18798C-819A-4BE2-BE3C-9E99A34CD2D4

Q30983821-35D2C624-706D-4102-82C5-0439F1F29638

Q30983821-3ED2DB04-7926-4AC9-A8D1-309301550DD8

Q30983821-3F90C066-CAFF-4BA0-96B0-3CCF8AFCDE93

Q30983821-444FCC0B-68EB-4B28-83D4-D5C70204A456

Q30983821-57D4536C-A29E-425C-B13A-40AEBDFE154B

P2888

Q30983821-8B8EA05B-6E70-489E-BDF1-A55596453956

P304

Q30983821-8DBD887C-F4AD-4B8C-AD70-FAB5C2765C4A

P31

Q30983821-368E8DB4-55CC-49EA-9E54-77E3A391DC05

P356

Q30983821-7E197468-1913-4948-966D-80EE5715B42F

P478

Q30983821-FBE13A39-E580-4113-81CA-E317FDBB092E

P577

Q30983821-C25C1DCE-13E6-496D-AF46-EEEC8186C9B2

P5875

Q30983821-93522B67-C4AA-4974-A7AC-AEB3A92D0E2C

P6179

Q30983821-58B3B9C4-68D6-4B3F-A41D-F0F594DAFC27

P698

Q30983821-F1918AC5-04D6-4FE8-A6B2-8AB83536E3A3

P921

Q30983821-3A0659DE-BAC0-4AAF-88C7-F017644DFDC6

Q30983821-9F3E341E-C42D-46A8-9A46-BCFA16A4A20D

P932

Q30983821-56C51C2D-852F-415B-909E-52CC4AC7D2F4

P356

1471-2466-10-32

P1433

BMC Pulmonary Medicine

P1476

MRC chronic Dyspnea Scale: Rel ...... patients: a prospective study

@en

P2093

Charis Roussos

http://www.w3.org/2001/XMLSchema#string

Christina Sotiropoulou

http://www.w3.org/2001/XMLSchema#string

Christina Triantafillidou

http://www.w3.org/2001/XMLSchema#string

Effrosyni D Manali

http://www.w3.org/2001/XMLSchema#string

Joseph Milic-Emili

http://www.w3.org/2001/XMLSchema#string

Likourgos F Kolilekas

http://www.w3.org/2001/XMLSchema#string

Panagiotis Lyberopoulos

http://www.w3.org/2001/XMLSchema#string

Spyros A Papiris

http://www.w3.org/2001/XMLSchema#string

P2860

CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

ATS statement: guidelines for the six-minute walk test.

Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation.

Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

ATS/ACCP Statement on cardiopulmonary exercise testing.

P2888

1471-2466-10-32

P304

32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2466-10-32

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44637447

http://www.w3.org/2001/XMLSchema#string

P6179

1008193576

http://www.w3.org/2001/XMLSchema#string

P698

20509928

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

2893122

http://www.w3.org/2001/XMLSchema#string